Overview
Lobbying Costs
350,000€
Financial year: Jan 2015 - Dec 2015
Lobbyists (Full time equivalent)
0.75 Fte (2)
Lobbyists with EP accreditation
2
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
Grünenthal GmbH (Grünenthal)
EU Transparency Register
67826544528-01 First registered on 14 Nov 2010
Goals / Remit
The Grünenthal Group is an independent, family-owned, international research-based pharmaceutical company headquartered in Aachen, Germany. We are an entrepreneurial specialist delivering true benefits to patients. By sustainably investing in research and development above the industrial average, we are committing to innovation in order to treat unmet medical needs and bring value-adding products to markets.
Grünenthal is one of five remaining research-oriented pharmaceutical companies with headquarters in Germany which sustainably invests in research and development. Research and development costs amounted to about 19 percent of revenues in 2015. Grünenthal's research and development strategy concentrates on selected fields of therapy and state-of-the-art technologies. We are intensely focused on discovering new ways to treat pain better and more effectively, with fewer side-effects than current therapies.
Altogether, the Grünenthal Group is present in 32 countries with affiliates in Europe, Latin America and the US. Grünenthal products are sold in more than 155 countries and currently approx. 5.400 employees are working for the Grünenthal Group worldwide. In 2015, Grünenthal achieved revenues of 1.212 Mio €
More information: www.grunenthal.comMain EU files targeted
Grünenthal interests in Brussels deal with issues related to health- and pain care, pharmaceuticals, innovation, research and intellectual property.
Address
Head Office
Zieglerstraße, 6
Aachen D-52099
GERMANY -
People
Total lobbyists declared
2
Employment time Lobbyists 50% 1 25% 1 Lobbyists (Full time equivalent)
0.75
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
2 accreditations were / are live (in bold) for the selected state of 05 Mar 2017
Name Start date End Date Ms Gudula Maria Petersen 14 Jun 2018 14 Jun 2019 Mr Theodorus Norbertus Maria van Rooij 17 Oct 2017 17 Oct 2018 Ms Gudula Maria Petersen 12 May 2017 09 May 2018 Mr Theodorus Norbertus Maria van Rooij 10 Oct 2016 05 Oct 2017 Ms Gudula Maria Petersen 29 Apr 2016 29 Apr 2017 Mr Theodorus Norbertus Maria van Rooij 24 Sep 2015 19 Sep 2016 Mr Konrad Labuschagne 21 May 2014 05 Jun 2015 Mr Konrad Labuschagne 25 May 2013 21 May 2014 Mrs Kristina Barinka 02 Mar 2013 29 Mar 2014 Mr Konrad Labuschagne 19 Jun 2012 17 Jun 2013 Mr Theodorus Norbertus Maria van Rooij 24 Mar 2012 01 Dec 2012 Mrs Kristina Barinka 24 Mar 2012 01 Dec 2012 Complementary Information
In 2015 0,5 FTE -
In 2016 05 FT + 0,25 FTEPerson in charge of EU relations
Mr Norbert van Rooij (Governmental Affairs and Health Policy)
Person with legal responsibility
Mr Gabriel Baertschi (Chairman of the Corporate Executive Board)
-
Categories
Category
II - In-house lobbyists and trade/business/professional associations
Subcategory
Companies & groups
-
Networking
Affiliation
Grünenthal is a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA): http://www.efpia.eu
Grünenthal supports the platform the Societal Impact of Pain (SIP). More info can be found here: https://www.sip-platform.euMember organisations
None declared
-
Financial Data
Closed financial year
Jan 2015 - Dec 2015
Lobbying costs for closed financial year
350,000€
EU grant income for closed financial year
129,149 € (Source: Horizon2020, http://cordis.europa.eu/project/rcn/193943_en.html)
Other financial info
The estimate of the annual costs related to activities covered by the register is based on a percentage of the salaries of the staffers in 2015 falling under the scope of the Register, based on the proportion of employee time spent on these activities.
Furthermore we have included consultancy costs, member association fees and support of health policy related activities in Brussels.. -
EU Structures
Groups (European Commission)
None
ACC
None
Groups (European Parliament)
None
Communication activities
None foreseen
Other activities
May 23 2016 Grünenthal was one of the organising partner in the Symposium “Societal Impact of Pain” (SIP) 2016: “Time for action”. The Worksgroup meetings of this sympsoium took place in the European Parliament (https://www.sip-platform.eu/events/sip-2016/program.html )
- Meetings
Meetings
None declared
- Meetings